: Does VEGFC modify the glomerular endothelial glycocalyx to protect from albuminuria?

Foster, R R (Principal Investigator)

Bristol Medical School (THS)

Status	Finished
Effective start/end date	1/04/15 → 1/06/16

Research Groups and Themes

Bristol Heart Institute

1 Article (Academic Journal)

VEGFC reduces glomerular albumin permeability and protects against alterations in VEGF receptor expression in diabetic nephropathy
Onions, K. L., Gamez, M., Buckner, N. R., Baker, S. L., Betteridge, K. B., Desideri, S., Dallyn, B. P., Ramnath, R. D., Neal, C. R., Farmer, L. K., Mathieson, P. W., Gnudi, L., Alitalo, K., Bates, D. O., Salmon, A. H. J., Welsh, G. I., Satchell, S. C. & Foster, R. R., 1 Jan 2019, In: Diabetes. 68, 1, p. 172-187 16 p.
Research output: Contribution to journal › Article (Academic Journal) › peer-review

Open Access
File
54 Citations (Scopus)

378 Downloads (Pure)

1 Invited talk

11TH INTERNATIONAL PODOCYTE CONFERENCE
Foster, R. R. (Speaker)
4 Apr 2016
Activity: Participating in or organising an event types › Invited talk